Peel Hunt reissued their buy rating on shares of ConvaTec Group (LON:CTEC) in a research note released on Thursday, ThisIsMoney.Co.Uk reports.
Several other analysts have also recently commented on the stock. Barclays set a $24.00 price target on shares of Tenet Healthcare and gave the company a hold rating in a research note on Wednesday, April 17th. Numis Securities reissued a buy rating and set a GBX 200 ($2.61) price target on shares of ConvaTec Group in a research note on Friday, May 3rd. JPMorgan Chase & Co. cut shares of Aeroports de Paris from an overweight rating to a neutral rating in a research note on Thursday, May 9th. Citigroup decreased their price target on shares of Western Digital from $63.00 to $59.00 and set a buy rating on the stock in a research note on Tuesday, April 30th. Finally, Deutsche Bank cut shares of Cogent Communications from a buy rating to a hold rating in a research note on Thursday, May 2nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of GBX 153.60 ($2.01).
CTEC opened at GBX 145 ($1.89) on Thursday. ConvaTec Group has a one year low of GBX 113.25 ($1.48) and a one year high of GBX 240.50 ($3.14). The company has a debt-to-equity ratio of 101.69, a current ratio of 2.73 and a quick ratio of 1.72. The firm’s 50 day moving average is GBX 143.04. The company has a market capitalization of $2.87 billion and a PE ratio of 13.18.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Read More: Understanding Options Trading
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.